Next Article in Journal
Drug–Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians
Previous Article in Journal
Treating Deep-Seated Tumors with Radiodynamic Therapy: Progress and Perspectives
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 16
Issue 9
10.3390/pharmaceutics16091136
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Pharmaceutics 2023, 15(12), 2777.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Al Khatib et al. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. Pharmaceutics 2024, 15, 2777

by
Arwa Omar Al Khatib
1,2,
Mohamed El-Tanani
2,3 and
Hisham Al-Obaidi
1,*
1
School of Pharmacy, University of Reading, Reading RG6 6AD, UK
2
Faculty of Pharmacy, Al Ahliyya Amman University, Amman 19111, Jordan
3
College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates
*
Author to whom correspondence should be addressed.
Pharmaceutics 2024, 16(9), 1136; https://doi.org/10.3390/pharmaceutics16091136
Submission received: 16 August 2024 / Accepted: 26 August 2024 / Published: 28 August 2024
(This article belongs to the Section Drug Delivery and Controlled Release)
Browse Figure
Versions Notes
In the original publication [1], Figure 1 was created by an artificial intelligence (AI) tool but without disclosing the information in the Material and Methods section. The corrected Figure 1 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Al Khatib, A.O.; El-Tanani, M.; Al-Obaidi, H. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. Pharmaceutics 2023, 15, 2777. [Google Scholar] [CrossRef] [PubMed]
Pharmaceutics 16 01136 g001
Figure 1. Examples of current drug delivery strategies for the treatment of NSCLC.
Figure 1. Examples of current drug delivery strategies for the treatment of NSCLC.
Pharmaceutics 16 01136 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Al Khatib, A.O.; El-Tanani, M.; Al-Obaidi, H. Correction: Al Khatib et al. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. Pharmaceutics 2024, 15, 2777. Pharmaceutics 2024, 16, 1136. https://doi.org/10.3390/pharmaceutics16091136

AMA Style

Al Khatib AO, El-Tanani M, Al-Obaidi H. Correction: Al Khatib et al. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. Pharmaceutics 2024, 15, 2777. Pharmaceutics. 2024; 16(9):1136. https://doi.org/10.3390/pharmaceutics16091136

Chicago/Turabian Style

Al Khatib, Arwa Omar, Mohamed El-Tanani, and Hisham Al-Obaidi. 2024. "Correction: Al Khatib et al. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. Pharmaceutics 2024, 15, 2777" Pharmaceutics 16, no. 9: 1136. https://doi.org/10.3390/pharmaceutics16091136

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop